CERO: CERo Therapeutics Holdings Inc

CERO News

• Investing 12:14 Cero Therapeutics regains Nasdaq compliance after bid price deficiency
• Investing 00:08 Cero Therapeutics adds institutional investors in Series D preferred stock sale
• Investing 11:48 Cero Therapeutics stock rating upgraded to Buy on solid tumor approach
• Investing 20:30 U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.10%
• Benzinga 16:55 Dow Surges 150 Points; Korn Ferry Earnings Top Views - CERo Therapeutics Hldgs (NASDAQ:CERO), Aptevo Therapeutics (NASDAQ:APVO)
• Benzinga 12:35 Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Aurora Cannabis (NASDAQ:ACB), Bitdeer Technologies (NASDAQ:BTDR)
• Benzinga 10:14 Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Acurx Pharmaceuticals (NASDAQ:ACXP), Biomea Fusion (NASDAQ:BMEA)
• Investing 20:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70%
• Investing 20:07 CERo Therapeutics stock soars after FDA grants Orphan Drug Designation
• Benzinga 18:16 Crude Oil Rises Sharply; Jabil Earnings Top Views - CERo Therapeutics Hldgs (NASDAQ:CERO), Acurx Pharmaceuticals (NASDAQ:ACXP)
• Benzinga 14:34 US Stocks Lower; Retail Sales Decline In May - CERo Therapeutics Hldgs (NASDAQ:CERO), Acurx Pharmaceuticals (NASDAQ:ACXP)
• Benzinga 14:03 What's Going On With Cero Therapeutics Stock Tuesday? - CERo Therapeutics Hldgs (NASDAQ:CERO)
• Investing 12:20 FDA grants orphan drug status to CERo’s leukemia treatment
• Investing 20:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.79%
• Investing 13:21 CERo Therapeutics to implement 1-for-20 reverse stock split
• TipRanks 15:54 Upcoming Stock Splits This Week (June 9 to June 13) – Stay Invested - TipRanks.com
• Investing 12:21 CERo Therapeutics issues additional Series D stock
• Investing 13:20 CERo Therapeutics Holdings, Inc. Announces Continued Enhancement of Intellectual Property Portfolio with Two Granted U.S. Patents and European Patent Application Allowance Regarding Company’s Lead
• Investing 13:49 CERO stock plunges to 52-week low at $0.47 amid market challenges
• Investing 12:21 CERo Therapeutics begins phase 1 trial for leukemia treatment
• Investing 13:59 CERO stock plunges to 52-week low of $0.53 amid market challenges
• Investing 15:26 Maxim Group sets Cero Therapeutics stock with $3 target
• Benzinga 17:11 Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results - ASGN (NYSE:ASGN), Bristol-Myers Squibb (NYSE:BMY)
• Benzinga 15:06 Dow Jumps Over 200 Points; PepsiCo Cuts Earnings Outlook - CERo Therapeutics Hldgs (NASDAQ:CERO), Cantor Equity Partners (NASDAQ:CEP)